DD284045A5 - Verfahren zur herstellung von desulfarohirudinmutanten - Google Patents

Verfahren zur herstellung von desulfarohirudinmutanten Download PDF

Info

Publication number
DD284045A5
DD284045A5 DD89330938A DD33093889A DD284045A5 DD 284045 A5 DD284045 A5 DD 284045A5 DD 89330938 A DD89330938 A DD 89330938A DD 33093889 A DD33093889 A DD 33093889A DD 284045 A5 DD284045 A5 DD 284045A5
Authority
DD
German Democratic Republic
Prior art keywords
gin
asn
arg
lys
desulphatohirudin
Prior art date
Application number
DD89330938A
Other languages
German (de)
English (en)
Inventor
Andrew Wallace
Stanley Dennis
Jan Hofsteenge
Stuart R Stone
Original Assignee
����`��@���k��
���@���`������@��k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ����`��@���k��, ���@���`������@��k�� filed Critical ����`��@���k��
Publication of DD284045A5 publication Critical patent/DD284045A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/815Protease inhibitors from leeches, e.g. hirudin, eglin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
DD89330938A 1988-07-19 1989-07-18 Verfahren zur herstellung von desulfarohirudinmutanten DD284045A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888817160A GB8817160D0 (en) 1988-07-19 1988-07-19 Novel proteins

Publications (1)

Publication Number Publication Date
DD284045A5 true DD284045A5 (de) 1990-10-31

Family

ID=10640714

Family Applications (1)

Application Number Title Priority Date Filing Date
DD89330938A DD284045A5 (de) 1988-07-19 1989-07-18 Verfahren zur herstellung von desulfarohirudinmutanten

Country Status (13)

Country Link
EP (1) EP0352228A3 (da)
JP (1) JPH02117694A (da)
KR (1) KR900001848A (da)
AU (1) AU3804589A (da)
DD (1) DD284045A5 (da)
DK (1) DK355189A (da)
FI (1) FI893451A (da)
GB (1) GB8817160D0 (da)
HU (1) HUT51671A (da)
IL (1) IL91003A0 (da)
NO (1) NO892949L (da)
PT (1) PT91190A (da)
ZA (1) ZA895460B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU614121B2 (en) * 1988-05-04 1991-08-22 Novartis Ag Improvements in the production of polypeptides
DE4009268A1 (de) * 1990-03-22 1991-09-26 Consortium Elektrochem Ind Sekretion von hirudinderivaten
GB9010552D0 (en) * 1990-05-10 1990-07-04 Erba Carlo Spa Method for the recombinant production of hirudins and novel hirudins
US6060451A (en) * 1990-06-15 2000-05-09 The National Research Council Of Canada Thrombin inhibitors based on the amino acid sequence of hirudin
US6514730B1 (en) 1991-03-21 2003-02-04 Consortium für elektrochemische Industrie GmbH Secretion of hirudin derivatives
US5837808A (en) * 1991-08-20 1998-11-17 Baxter International Inc. Analogs of hirudin
US6274553B1 (en) 1997-01-20 2001-08-14 Japan Energy Corporation Method for stabilizing peptides and freeze-dried medicinal compositions containing peptides obtained by using the method
EP1597279A1 (en) * 2003-02-27 2005-11-23 National Research Council Of Canada Peptide inhibitors of thrombin as potent anticoagulants
US7795205B2 (en) 2004-04-12 2010-09-14 Canyon Pharmaceuticals, Inc. Methods for effecting regression of tumor mass and size in a metastasized pancreatic tumor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE64956T1 (de) * 1984-06-14 1991-07-15 Ciba Geigy Ag Verfahren zur herstellung von thrombininhibitoren.
EP0209061B1 (de) * 1985-07-17 1994-01-12 Hoechst Aktiengesellschaft Neue Polypeptide mit blutgerinnungshemmender Wirkung, Verfahren zu deren Herstellung bzw. Gewinnung, deren Verwendung und diese enthaltende Mittel
FR2607517B2 (fr) * 1986-12-01 1989-12-22 Transgene Sa Vecteurs d'expression de variants de l'hirudine dans les levures, procede et produit obtenu

Also Published As

Publication number Publication date
PT91190A (pt) 1990-02-08
HUT51671A (en) 1990-05-28
JPH02117694A (ja) 1990-05-02
IL91003A0 (en) 1990-02-09
ZA895460B (en) 1990-02-28
FI893451A0 (fi) 1989-07-17
FI893451A (fi) 1990-01-20
DK355189D0 (da) 1989-07-18
NO892949D0 (no) 1989-07-18
NO892949L (no) 1990-01-22
GB8817160D0 (en) 1988-08-24
EP0352228A2 (en) 1990-01-24
AU3804589A (en) 1990-01-25
DK355189A (da) 1990-01-20
EP0352228A3 (en) 1990-07-11
KR900001848A (ko) 1990-02-27

Similar Documents

Publication Publication Date Title
EP0168342B1 (de) Verfahren zur Herstellung von Thrombin-Inhibitoren
DE3050722C2 (da)
EP0307592B1 (de) Varianten des pankreatischen Rinder-Trypsininhibitors, deren Herstellung und Verwendung
DD296965A5 (de) Hefeverarbeitungssystem
EP0293567B1 (de) Vascular-antikoagulierende Proteine, DNA die diese kodieren, Verfahren zu deren Herstellung sowie deren Verwendung
DD229427A5 (de) Verfahren zur gewinnung eines polypeptids
DD216044A5 (de) Verfahren zur herstellung eines rekombinierenden dna-klonierungsvektors
DD297188A5 (de) Gm-csf und il-3 umfassende fusionsproteine
DE3144469A1 (de) Hybride human-leukozyten-interferone
DE3712985A1 (de) Bifunktionelle proteine
DD284045A5 (de) Verfahren zur herstellung von desulfarohirudinmutanten
DE3600571A1 (de) Dna-sequenzen, die fuer proteine mit der biologischen aktivitaet der husi-typi-inhibitoren codieren, gentechnologische verfahren zur herstellung dieser proteine und diese proteine enthaltende arzneimittel
DE3419995A1 (de) Gentechnologisches verfahren zur herstellung von human-interleukin-2 und mittel zur durchfuehrung dieses verfahrens
CH676990A5 (da)
EP0297362A2 (de) Human-Aprotinin, dessen Lys-Rest in Position 15 gegen einen anderen protogenen Aminosäurerest ausgetauscht ist
DE3716722A1 (de) Gentechnologisches verfahren zur herstellung von angiogeninen
DD284044A5 (de) Verfahren zur herstellung von desulfatohirudinmutanten
EP0677107B1 (de) Thrombininhibitor aus speichel von protostomiern
DD274053A5 (de) Verfahren zur Produktion eines menschlichen, einkettigen Plasminogenaktivators
DE3724581A1 (de) Dna-sequenzen, die fuer proteine mit den biologischen eigenschaften des cystatin c codieren, herstellung dieser dna-sequenzen, expression des cystatin c sowie dieses enthaltende pharmazeutische zubereitungen
EP0332576B1 (de) Modifizierte Proteine
EP0496327B1 (de) Verfahren zur Herstellung von Polypeptiden mit Prourokinase-Aktivität
DE69432975T2 (de) Tryptase hemmer
EP1002083A1 (de) Aprotininvarianten mit verbesserten eigenschaften und bikunine von aprotininvarianten
DE3710430A1 (de) Vascular-antikoagulierende proteine, dna die diese kodieren, verfahren zu deren herstellung sowie deren verwendung

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee